Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rangering i aksjer #17186
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Aksjekurs
$2.17
Markedsverdi
$249.58M
Endring (1 dag)
-1.67%
Endring (1 år)
96.34%
Land
CA
Handel Cardiol Therapeutics Inc. (CRDL)

Kategori

Aksjeprishistorikk for Cardiol Therapeutics Inc. (CRDL)
Høyeste sluttskurs: $2.19 den 2026-09-01

Laveste sluttskurs: $3.27 den 2018-12-01
Aksjeprishistorikk for Cardiol Therapeutics Inc. fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 17.15%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$165.17 31.41%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.98 26.11%
CH